Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$751M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$692M |
| 3 |
Palantir
PLTR
|
+$434M |
| 4 |
Union Pacific
UNP
|
+$377M |
| 5 |
AbbVie
ABBV
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.74B |
| 2 |
Meta Platforms (Facebook)
META
|
+$602M |
| 3 |
Bank of America
BAC
|
+$600M |
| 4 |
Wells Fargo
WFC
|
+$568M |
| 5 |
Broadcom
AVGO
|
+$538M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.73% |
| 2 | Financials | 7.42% |
| 3 | Healthcare | 6.65% |
| 4 | Industrials | 6.3% |
| 5 | Consumer Discretionary | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Republic Bancorp
RBCAA
$1.95B
| $1.71M | ﹤0.01% |
23,394
-11,691
| -33% | -$799K |
|
3902
Protara Therapeutics
TARA
$220M
| $1.71M | ﹤0.01% |
564,120
-4,301
| -0.8% | -$14.8K |
|
3903
Utah Medical Products
UTMD
$225M
| $1.71M | ﹤0.01% |
29,980
-2,028
| -6% | -$110K |
|
3904
PUT
Shake Shack
SHAK
$2.53B
| $1.7M | ﹤0.01% |
12,100
-20,700
| -63% | -$2.25M |
|
3905
Atossa Therapeutics
ATOS
$20.6M
| $1.7M | ﹤0.01% |
+136,502
| New | +$1.63M |
|
3906
Allogene Therapeutics
ALLO
$649M
| $1.7M | ﹤0.01% |
1,502,724
+1,245,875
| +485% | +$1.66M |
|
3907
News Corp Class B
NWS
$16.9B
| $1.7M | ﹤0.01% |
+49,449
| New | +$1.57M |
|
|
WSR
3908
DELISTED
Whitestone REIT
WSR
| $1.7M | ﹤0.01% |
135,885
-76,350
| -36% | -$972K |
|
3909
SES AI
SES
$203M
| $1.69M | ﹤0.01% |
1,906,619
+1,285,343
| +207% | +$1.08M |
|
3910
CALL
SolarEdge
SEDG
$2.51B
| $1.69M | ﹤0.01% |
82,900
-4,600
| -5% | -$76.1K |
|
3911
Amdocs
DOX
$5.92B
| $1.69M | ﹤0.01% |
18,480
-48,567
| -72% | -$4.34M |
|
3912
Encore Capital Group
ECPG
$2.02B
| $1.68M | ﹤0.01% |
43,508
+20,533
| +89% | +$745K |
|
3913
Holley
HLLY
$321M
| $1.68M | ﹤0.01% |
837,656
+616,593
| +279% | +$1.31M |
|
3914
CALL
Evolus
EOLS
$385M
| $1.68M | ﹤0.01% |
+181,900
| New | +$1.86M |
|
3915
PepGen
PEPG
$122M
| $1.68M | ﹤0.01% |
1,509,198
+476,180
| +46% | +$673K |
|
3916
CALL
Bunge Global
BG
$20.4B
| $1.67M | ﹤0.01% |
20,800
+1,100
| +6% | +$86.6K |
|
3917
CALL
Clorox
CLX
$11.6B
| $1.67M | ﹤0.01% |
13,900
+8,800
| +173% | +$1.17M |
|
3918
PUT
Teva Pharmaceuticals
TEVA
$40.8B
| $1.67M | ﹤0.01% |
99,500
-60,400
| -38% | -$975K |
|
3919
Greene County Bancorp
GCBC
$570M
| $1.66M | ﹤0.01% |
74,639
+19,039
| +34% | +$422K |
|
3920
Bridgewater Bancshares
BWB
$571M
| $1.66M | ﹤0.01% |
104,164
+76,559
| +277% | +$1.12M |
|
3921
CALL
TripAdvisor
TRIP
$1.65B
| $1.65M | ﹤0.01% |
126,800
-99,600
| -44% | -$1.33M |
|
3922
CALL
BHP
BHP
$215B
| $1.65M | ﹤0.01% |
34,400
-16,100
| -32% | -$774K |
|
3923
Red Violet
RDVT
$979M
| $1.65M | ﹤0.01% |
33,607
+258
| +0.8% | +$11.3K |
|
3924
Leslie's
LESL
$8.9M
| $1.65M | ﹤0.01% |
196,693
+53,129
| +37% | +$699K |
|
3925
AirSculpt Technologies
AIRS
$339M
| $1.65M | ﹤0.01% |
+341,834
| New | +$1.16M |
|
Similar funds
Millennium Management's Q2 2025 Portfolio in Review
As of Q2 2025, Millennium Management held 6,516 positions worth $207B, up 10% from $188B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Millennium Management's Q2 2025 filing shows 738 new, 2,295 increased, 2,418 reduced and 712 closed positions. Its largest new stake was Bank of America Series L: 164,000 shares worth $197K. The largest sale was iShares Core S&P 500 ETF, an estimated $1.74B.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 7.8% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q2 2025 buy was Bank of America Series L: 164,000 shares worth $197K.
- Millennium Management added most to Applovin in Q2 2025, an estimated $751M increase.
- Millennium Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.74B.
- Millennium Management fully exited Discover Financial Services in Q2 2025, selling an estimated $282M.
- Millennium Management's ten largest holdings make up 16% of its $207B portfolio in Q2 2025.
- Millennium Management opened 738 new positions and closed 712 in Q2 2025.
- Millennium Management's portfolio value rose 10% quarter-over-quarter to $207B.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.